The principal objective in a new drug development program is to assess the benefit / risk ratio. Learn what the risk information is that must be collected, documented and reported accurately.
The Risk to Subject Safety of Not Accurately Reporting Adverse Events - How to Assess and report AEs and SAEs - By GlobalCompliancePanel
14 June 2011, Wilmington, United States
Introduction
Venue
Online Training Webinars
Online Training Webinars, 1000 N West Street | Suite 1200, Wilmington, 19801, United States
Useful links
Contact information
Related events
The PFAS dilemma - outright ban vs essential utility?
2 May 2024 19:00-20:30, Belfast, United Kingdom
Forensic serology and DNA analysis laboratory training
27 May 2024 09:00 - 31 May 2024 16:00, KISUMU, Kenya
Future Labs Live
26 June 2024 08:00 - 27 June 2024 17:00, Basel, Switzerland
35th Medicinal Chemistry in Eastern England
25 April 2024 09:00-17:00, Hatfield, United Kingdom
Search
Advertisement
Spotlight
Explore
